- Home
- GOSS vs PINE Comparison
GOSS vs PINE Comparison
Compare GOSS & PINE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GOSS
- PINE
- Stock Information
- Founded
- GOSS 2015
- PINE 2019
- Country
- GOSS United States
- PINE United States
- Employees
- GOSS N/A
- PINE N/A
- Industry
- GOSS Biotechnology: Pharmaceutical Preparations
- PINE Real Estate Investment Trusts
- Sector
- GOSS Health Care
- PINE Real Estate
- Exchange
- GOSS Nasdaq
- PINE Nasdaq
- Market Cap
- GOSS 212.8M
- PINE 245.5M
- IPO Year
- GOSS 2019
- PINE 2019
- Fundamental
- Price
- GOSS $1.40
- PINE $16.48
- Analyst Decision
- GOSS Strong Buy
- PINE Strong Buy
- Analyst Count
- GOSS 5
- PINE 9
- Target Price
- GOSS $9.20
- PINE $19.72
- AVG Volume (30 Days)
- GOSS 1.6M
- PINE 104.8K
- Earning Date
- GOSS 03-04-2025
- PINE 02-06-2025
- Dividend Yield
- GOSS N/A
- PINE 6.83%
- EPS Growth
- GOSS N/A
- PINE N/A
- EPS
- GOSS N/A
- PINE 0.14
- Revenue
- GOSS $105,322,000.00
- PINE $52,227,000.00
- Revenue This Year
- GOSS N/A
- PINE N/A
- Revenue Next Year
- GOSS N/A
- PINE $4.37
- P/E Ratio
- GOSS N/A
- PINE $117.64
- Revenue Growth
- GOSS N/A
- PINE 14.42
- 52 Week Low
- GOSS $0.50
- PINE $14.33
- 52 Week High
- GOSS $1.60
- PINE $19.42
- Technical
- Relative Strength Index (RSI)
- GOSS 67.09
- PINE 47.19
- Support Level
- GOSS $1.37
- PINE $16.39
- Resistance Level
- GOSS $1.55
- PINE $16.91
- Average True Range (ATR)
- GOSS 0.13
- PINE 0.33
- MACD
- GOSS 0.03
- PINE -0.00
- Stochastic Oscillator
- GOSS 75.81
- PINE 42.50
About GOSS Gossamer Bio Inc.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.
About PINE Alpine Income Property Trust Inc.
Alpine Income Property Trust Inc is a real estate company. It owns and operates a portfolio of single-tenant commercial properties. The company's portfolio is comprised of single-tenant retail and office properties located in or in close proximity to MSAs, growth markets and other markets in the United States. Their portfolio consists of One thirty eight net leased properties located in Hundred and four markets in thirty five states. The majority of the firm's revenue includes rental revenue derived from the ownership and leasing of property.